| www.bioportfolio.com |
http://www.bioportfolio.com/bulletin_40.htm
May
25th 2004
|
|
| VIROPHARMA
AUCTION - Lab Equipment at a 100,000 Square Foot Ultra-Modern
Biopharmaceutical Research and Development Facility |
 |
VIROPHARMA AUCTION
Private Treaty Sale Followed By a 1-Day Webcast Auction of Lab
Equipment at a 100,000 Square Foot Ultra-Modern Biopharmaceutical
Research and Development Facility. Orderly Liquidation Accepting
Offers Now Until June 2, 2004. Webcast Auction Wednesday, June 9,
2004 Beginning at 9:00 AM (ET). Bid Live in Exton, PA or on
DoveBid's website: www.dovebid.com.
For more information, visit our website or call 800-665-1042.
http://www.dovebid.com/Auctions/AuctionDetail.asp?auctionID=2554&referraltag=viro1c
|
|
|
In
this Week's issue:
1) Dovebid - major sale of Biotechnology,
Pharmaceutical and Laboratory equipment - see above
2) Event not to be missed - BIOPHEX
2004 Conference - from post-discovery to
market
3) Reuters Business Insight OFFER
- Commercial
Opportunities from an Aging Population - 50% off second report
4) BioNewsCast -
getting your news onto MSN Newsbot
5) BioNews
- the most comprehensive life science news
6) BioAnnouncements - promoting
technology to the life science sector |
|
| BIOPHEX
2004 Conference - from post-discovery to market |
 |
|
BIOPHEX
delivers a unique perspective on the strategic and managerial issues that
affect everyone in post-discovery development and manufacturing. The
conference, produced by Genetic Engineering News, is targeted to help
top-level biopharmaceutical professionals successfully transition their drug
from post-discovery to market. For more information open:
http://www.biophex.com.
|
| Reuters
Business Insight OFFER - Commercial
Opportunities from an Aging Population |
 |
|
The
new Reuters Business Insight report: 'Commercial
Opportunities from an Aging Population: Epidemiology market and pipeline
analysis across seven major indications'
evaluates the benefits and rewards of marketing to seniors for the
pharmaceutical industry.
Current
and future growth prospects are examined for pharmaceutical companies to
2008 in seven major indications particularly associated with seniors, these
are:
-
Acute
ischemic stroke
-
Alzheimer's
disease
-
Arthritis
-
Diabetes
-
Male
sexual dysfunction
-
Osteoporosis
-
Prostate
cancer
Globally,
the number of older people will increase from 606m in 2000 to 1.9bn in 2050
and as a result healthcare needs will increase and drugs will be used for
longer. This report highlights strategies that will show you:
-
How
to exploit increased contact between seniors and physicians
-
How
to meet seniors health information needs
-
How
to harness web technology to communicate with seniors.
Special
Offer - SAVE £373/$600/€600
Order
your copy of "Commercial Opportunities from an Aging Population"
before Friday 28th May 2004, and receive one of the following management
reports for half price saving you £373/$600/€600:
The
Women's Health Outlook to 2008
or
The
CNS market Outlook to 2008
Reuters
Business Insight reports are published by Datamonitor, in association with
Reuters. Reuters, the sphere logo and Reuters Business Insight are trade
marks of the Reuters group of companies around the world and are used by
Datamonitor under licence from Reuters.
To order email peter.barfoot@bioportfolio.com
or purchase online at:
http://www.bioportfolio.com/cgi-bin/acatalog/Reuters_Business_Insight_2004.html
|
| BioNewsCast
- getting your press releases pushed onto the internet |
 |
|
BioPortfolio's
BioNewsCast service ensures that your press releases are seen quickly
by the right audience using all the benefits of internet technologies. This
exceptional value-for-money service complements your conventional routes to
the media networks. To evaluate the BioNewsCast Services - Click
here!
Simply e-mail your release to peter.barfoot@bioportfolio.com
to ensure rapid global distribution through the Moreover.com biotechnology
and pharmaceutical newsfeeds, used on thousands of internet sites, by
hundreds of press editors and thousands of internet users - including YAHOO
and Ask Jeeves search engines.
Your release will also feature in the BioPortfolio.com BioNews search engine
and alert service used by BioPortfolio's targeted biotechnology and
pharmaceutical readership.
> Targeted PR to the bio/pharma sector
> Distributed via Moreover.com the global internet news consolidator
> Features immediately on the BioPortfolio and Moreover news search
engines + MSN and Ask Jeeves search engines.
> Stays on the BioPortfolio site for 12 months
> No restrictions on Press Release length
> Competitive flat rate pricing
How it works
1) Decide on your subscription level from 1 to 40 press releases
2) Purchase
space using VISA, MasterCard or AMEX
3) Email press releases in either WORD, text, html or relevant URL to peter.barfoot@bioportfolio.com
4) BioPortfolio confirms by email when published
Download
pdf brochure now!
|
| BioNews
- the most comprehensive life science news |
| Click
on the news title for detailed news:
Also news by publishers, regions, sector -
click here!
|
|
| BioAnnouncements
- promoting technology to the life science sector |
| Do
you have technology that you wish to license?
Do you want to contact 50,000 life science
users?
Complete the online enquiry form - click
here!
|
|
In
2004, LeadDiscovery & BioPortfolio, two of the largest
drug development information providers combined their resources to launch BioAnnouncements.
Through this service, LeadDiscovery distributes dedicated mail shots
announcing licensing opportunities and R&D services to the drug
discovery community.
Interested? Email: leaddiscovery@leaddiscovery.co.uk
Read more: http://www.leaddiscovery.co.uk/adpage.html
|
|
|
Contact
us:
Editorial and features: peter.barfoot@bioportfolio.com
Subscriber
information:
To subscribe for the
BioPortfolio Bulletin in HTML, email:
bioportfolio-subscribe-request@peach.ease.lsoft.com
To unsubscribe,
email: bioportfolio-signoff-request@peach.ease.lsoft.com
WITH NO SUBJECT. The system will automatically remove your email
address from the list based on your email address. If your email has
changed please email peter.barfoot@bioportfolio.com
with a list of your email address and we will manually unsubscribe for you.
Thank you for your understanding.
©2004
BioPortfolio Limited
|
